Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects

Pieter Jan De Kam, Annelieke C. Kruithof, Marie José Van Lierop, Matthijs Moerland, Justin Dennie, Matthew D. Troyer, Ronald B. Langdon, David E. Gutstein, Jacobus Burggraaf, Rachid El Galta

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects'. Together they form a unique fingerprint.

Medicine & Life Sciences